Melanoma insights

Interviews with the experts

Two key opinion leaders, Dr. Reinhard G. Dummer of the University of Zurich Hospital, Zurich, Switzerland, and Dr. Paolo A. Ascierto of the National Tumour Institute, Fondazione G. Pascale, Naples, Italy, speak about current successes and challenges in the treatment of metastatic melanoma.

Meet Dr. Ascierto
Meet Dr. Dummer
Unmet need in NRAS-mutant melanoma Learn More >
Mutations in NRAS vs BRAF: same pathway, different disease Learn More >
What else is different about NRAS-mutant disease? Learn More >
Disease can be aggressive with NRAS mutation Learn More >
The potential role of MEK inhibitors Learn More >
NRAS testing—the standard of care? Learn More >
Approach to new patients Learn More >
Biomarkers in advanced melanoma Learn More >
Next: Resources

You are now leaving NRASmatters.com

The website you are linking to is neither owned nor controlled by Array BioPharma. Array BioPharma is not responsible for the content or services on the site.

Cancel
Continue